In a pilot trial of 34 postpartum people with methamphetamine use disorder, micronized progesterone for 12 weeks vs placebo was feasible (91.8% of planned enrolment; 88% retention) with similar adverse events (78% vs 81%); return to methamphetamine use did not differ.
RCTn = 34
Smid et al. Prevention of postpartum methamphetamine use with micronized progesterone trial (PROMPT): A pilot randomized controlled trial